MedTrace Logo

Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension

NCT03029416 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2018-10-15

No results posted yet for this study

Summary

30 Gy single fraction of SBRT for lung metastases will result in comparable oncologic outcomes to 18Gy in three fractions (or dosing to a BED \</-100Gy at the discretion of the radiation oncologist) with respect to disease control and toxicity.

Conditions

  • Neoplasm Metastasis
  • Cancer
  • Radiation Therapy Complication

Interventions

RADIATION

Stereotactic Body Radiation Therapy

Stereotactic Body Radiation Therapy using different fractionation schedules

Sponsors & Collaborators

  • Ronald McGarry

    lead OTHER

Principal Investigators

  • Ronald McGarry, MD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-26
Primary Completion
2018-07-20
Completion
2018-08-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03029416 on ClinicalTrials.gov